Clear Image Devices LLC (CiD) announced the release of its step platform to be used for standing patient ultrasound venous insufficiency studies. The Ultrasound Exam Steps enable sonographers to place the patient in the optimal position for safe, easy capture of the highest quality venous images of the upper and lower leg.
To help reduce the burden of cardiovascular disease, the nation's leading killer, New York-Presbyterian Hospital and Weill Cornell Medical College have created the Dalio Institute of Cardiovascular Imaging. Raymond T. Dalio, a life trustee of New York-Presbyterian Hospital, has made a gift of $20 million through his Dalio Foundation in support of the institute.
The Eurozone economic slowdown has made it difficult for hospitals, particularly in Southern Europe, to procure new imaging modalities. With streamlined budgets and escalating number of medical procedures, the need to spend less on technologies while gaining the maximum benefit from them has sustained demand for high-quality refurbished imaging equipment.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
The Society for Cardiovascular Angiography and Interventions (SCAI) published a first-of-its-kind paper defining best practices for the use of the transradial approach for diagnosing and treating blocked heart arteries.
InspireMD Inc., a developer of embolic protection stents, announced 12-month results from the MGuard for Acute ST Elevation Reperfusion (MASTER) trial demonstrating that the MGuard outperformed bare metal and drug-eluting stents in all-cause mortality in ST segment elevation myocardial infarction (STEMI) patients.
Lantheus Medical Imaging, Inc., a developer, manufacturer and distributor of diagnostic imaging agents, announced preliminary results from the first of two planned Phase 3 trials to assess the diagnostic efficacy of flurpiridaz F 18, an imaging agent used in positron emission tomography (PET) myocardial perfusion imaging (MPI) for the detection of coronary artery disease (CAD).
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
Petr Neuzil, M.D., Nemocnice Na Homolce Hospital, Prague, Czech Republic, presented three-month results from the WAVE II study and complete six-month results for the WAVE I (first-in-man) at the Transcatheter Cardiovascular Therapeutics conference (TCT 2013).
No law prevents doctors from freely prescribing U.S. Food and Drug Administration (FDA)-approved drugs and devices for off-label uses, yet regulators continue to aggressively pursue civil and criminal enforcement of perceived violations, warns Patrick J. Hurd, senior counsel with LeClairRyan in Washington, D.C. and Norfolk, Va. in the November 2013 edition of Westlaw Journal Pharmaceutical.
Medtronic Inc. announced that the U.S. Food and Drug Administration (FDA) has approved an Investigational Device Exemption (IDE), allowing the company to initiate SYMPLICITY HTN-4, the first randomized trial to investigate renal denervation for the treatment of moderate uncontrolled hypertension in U.S. patients.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
Aycan will feature its mobile iPad application, which is designed to quickly, easily and securely transfer DICOM images from hospitals and imaging centers to on-call and other radiologists and referring physicians with an iPad, at the Radiological Society of North America Annual Meeting (RSNA 2013) in Chicago.
NEC Display Solutions will be offering additional insight and demonstrations of its latest products including the MultiSync MD210C2 medical-grade monitor, built for the displaying and viewing of digital images for diagnosis by physicians, at the Radiological Society of North America Annual Conference (RSNA 2013) in Chicago.
Personnel of Wyle, a provider of engineering, scientific and technical service to the U.S. Department of Defense (DoD), at the Johnson Space Center have selected Fujifilm Medical Systems U.S.A. Inc. to implement Synapse Radiology and Synapse Cardiovascular to support NASA’s in-flight as well as ground-based clinical care operations.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
DAIC Editor Dave Fornell offers his choices of the most innovative new cardiovascular technologies discussed in sessions ...
Men undergoing testosterone therapy had a 29 percent greater risk of heart attack, stroke and death according to a study of a "real world" population of men.
Doctors have known for years that atrial fibrillation (AF) increases the risk for stroke, but now researchers at Wake Forest Baptist Medical Center have shown that it also increases the risk for heart attack.